Cargando…

Associations between the use of aspirin or other antiplatelet drugs and all-cause mortality among patients with COVID-19: A meta-analysis

Introduction: Whether aspirin or other antiplatelet drugs can reduce mortality among patients with coronavirus disease (COVID-19) remains controversial. Methods: We identified randomized controlled trials, prospective cohort studies, and retrospective studies on associations between aspirin or other...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Wanting, Miao, He, Guo, Zhaotian, Chen, Qianhui, Huang, Tao, Ding, Renyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581252/ https://www.ncbi.nlm.nih.gov/pubmed/36278186 http://dx.doi.org/10.3389/fphar.2022.989903

Ejemplares similares

Do Aspirin and Other Antiplatelet Drugs Reduce the Mortality in Critically Ill Patients?
por: Lösche, Wolfgang, et al.
Publicado: (2012)

Aspirin and antiplatelet treatments in cancer
por: Tao, Derrick L., et al.
Publicado: (2021)

Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis
por: Luo, Xiaofeng, et al.
Publicado: (2023)

Inhibition of Aspirin-Induced Gastrointestinal Injury: Systematic Review and Network Meta-Analysis
por: Zhang, Wan-tong, et al.
Publicado: (2021)

Systematic Review and Meta-analysis: Association of Aspirin With Incidence of Hepatocellular Carcinoma
por: Zhou, Xueliang, et al.
Publicado: (2022)

Plant Alkaloids as Antiplatelet Agent: Drugs of the Future in the Light of Recent Developments
por: Ain, Qurrat-Ul-, et al.
Publicado: (2016)

Low- or high-dose preventive aspirin use and risk of death from all-cause, cardiovascular disease, and cancer: A nationally representative cohort study
por: Chen, Yu, et al.
Publicado: (2023)

A New Score for Predicting Acute Gastrointestinal Bleeding in Patients Administered Oral Antiplatelet Drugs
por: Lv, Meina, et al.
Publicado: (2021)

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
por: Neubauer, Horst, et al.
Publicado: (2011)

Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography
por: Hemlata,, et al.
Publicado: (2013)

Dissolvable polymeric microneedles loaded with aspirin for antiplatelet aggregation
por: Wang, Baorui, et al.
Publicado: (2023)

Association Between Prior Aspirin Use and Acute Respiratory Distress Syndrome Incidence in At-Risk Patients: A Systematic Review and Meta-Analysis
por: Liang, Huoyan, et al.
Publicado: (2020)

Mechanism of Improving Aspirin Resistance: Blood-Activating Herbs Combined With Aspirin in Treating Atherosclerotic Cardiovascular Diseases
por: Zhao, Yixi, et al.
Publicado: (2021)

The effects and safety of anticoagulation or antiplatelet therapy following TIPS in cirrhotic patients with portal hypertension: A meta-analysis
por: Xu, Xiaotong, et al.
Publicado: (2023)

The Benefit and Safety of Aspirin for Primary Prevention of Ischemic Stroke: A Meta-Analysis of Randomized Trials
por: Lei, Hong, et al.
Publicado: (2016)

Effect of aspirin in patients with established asymptomatic carotid atherosclerosis: A systematic review and meta-analysis
por: Hu, Xianjin, et al.
Publicado: (2022)

Panax notoginseng preparation plus aspirin versus aspirin alone on platelet aggregation and coagulation in patients with coronary heart disease or ischemic stroke: A meta-analysis of randomized controlled trials
por: Dai, Lulu, et al.
Publicado: (2022)

Antiplatelet Agents Inhibit the Generation of Platelet-Derived Microparticles
por: Giacomazzi, Alice, et al.
Publicado: (2016)

Corrigendum: Association Between Prior Aspirin Use and Acute Respiratory Distress Syndrome Incidence in At-Risk Patients: A Systematic Review and Meta-Analysis
por: Liang, Huoyan, et al.
Publicado: (2020)

Aspirin in COVID-19: Pros and Cons
por: Zareef, Rana, et al.
Publicado: (2022)

Economic Evaluation of Ticagrelor Plus Aspirin Versus Aspirin Alone for Acute Ischemic Stroke and Transient Ischemic Attack
por: Chen, Jigang, et al.
Publicado: (2022)

Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc
por: Liu, Yingqiu, et al.
Publicado: (2018)

Clinical Outcomes of Concomitant Use of Proton Pump Inhibitors and Dual Antiplatelet Therapy: A Systematic Review and Meta-Analysis
por: Guo, Hongzhou, et al.
Publicado: (2021)

Co-prescribing of opioids and benzodiazepines/Z-drugs associated with all-cause mortality—A population-based longitudinal study in primary care with weak opioids most commonly prescribed
por: Linnet, Kristjan, et al.
Publicado: (2022)

Effect of Chinese herbal medicine therapy on risks of all-cause mortality, infections, parasites, and circulatory-related mortality in HIV/AIDS patients with neurological diseases
por: Chiou, Jian-Shiun, et al.
Publicado: (2023)

Association Between Aspirin Usage and Age-Related Macular Degeneration: An Updated Systematic Review and Meta-analysis
por: Yan, Ruijia, et al.
Publicado: (2022)

Commentary: Effect of aspirin in patients with established asymptomatic carotid atherosclerosis: a systematic review and meta-analysis
por: Spence, J. David
Publicado: (2023)

Aspirin reduces the mortality risk of sepsis-associated acute kidney injury: an observational study using the MIMIC IV database
por: Chen, Sining, et al.
Publicado: (2023)

Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease
por: Pi, Lei, et al.
Publicado: (2018)

A Novel Antiplatelet Aggregation Target of Justicidin B Obtained From Rostellularia Procumbens (L.) Nees
por: Yang, Yan-Fang, et al.
Publicado: (2019)

Antiplatelet and Antithrombotic Activity of a Traditional Medicine, Hwangryunhaedok-Tang
por: Kim, Kyungho, et al.
Publicado: (2019)

Antiplatelet Therapy in Atherothrombotic Diseases: Similarities and Differences Across Guidelines
por: Jourdi, Georges, et al.
Publicado: (2022)

Spironolactone Improves the All-Cause Mortality and Re-Hospitalization Rates in Acute Myocardial Infarction with Chronic Kidney Disease Patients
por: Qu, Xiang, et al.
Publicado: (2021)

All-cause and in-hospital mortality after aspirin use in patients hospitalized with COVID-19: a systematic review and meta-analysis
por: Baral, Nischit, et al.
Publicado: (2022)

Platelet-Derived Extracellular Vesicles as Target of Antiplatelet Agents. What Is the Evidence?
por: Taus, Francesco, et al.
Publicado: (2019)

Investigation of the Uptake and Transport of Aspirin Eugenol Ester in the Caco-2 Cell Model
por: Tao, Qi, et al.
Publicado: (2022)

Asthma and Rhinitis Induced by Selective Immediate Reactions to Paracetamol and Non-steroidal Anti-inflammatory Drugs in Aspirin Tolerant Subjects
por: Pérez-Alzate, Diana, et al.
Publicado: (2016)

Aspirin intervention before ICU admission reduced the mortality in critically ill patients with acute kidney injury: results from the MIMIC-IV
por: Meng, Yao, et al.
Publicado: (2023)

Treatment of Kawasaki Disease: A Network Meta-Analysis of Four Dosage Regimens of Aspirin Combined With Recommended Intravenous Immunoglobulin
por: Huang, Ying-Hua, et al.
Publicado: (2021)

Metabolomic Analysis of Platelets of Patients With Aspirin Non-Response
por: Chiang, Jiun-Yang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_94fagophru7mo610acrmvhb615